Tuesday, September 18, 2018
Citron reiterates $60 AbbVie target, says lawsuit ‘least of the problems’
Citron Research just tweeted, “$abbv being sued today by California for price collusion. This the least of the problems. Wait until the government starts exploring the rapid and unjustifiable death rate from Humira tgt $60.” Shares of AbbVie are down 2.5% to $92.97 in afternoon trading.
https://thefly.com/landingPageNews.php?id=2792215
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.